Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bridgewater

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
ESMO Open|March 13, 2022
Plasma Tie2 trajectories identify vascular response criteria for VEGF inhibitors across advanced biliary tract, colorectal and ovarian cancersC Zhou, J O'Connor, A Backen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2014
Phase II, randomized, biomarker identification trial (MARK) for erlotinib in patients with advanced pancreatic carcinomaD Propper, I Davidenko, J Bridgewater, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 23, 2008
Primary tumour resection and survival in the palliative management of metastatic colorectal cancerA Bajwa, N Blunt, S Vyas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2013
Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trialsJ W Valle, J Furuse, M Jitlal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 29, 2011
Cancer of unknown primary: progress in the search for improved and rapid diagnosis leading toward superior patient outcomesF A Greco, K Oien, M Erlander, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 8, 2010
Chemoradiotherapy with or without induction chemotherapy for locally advanced pancreatic cancer: a UK multi-institutional experienceR Gillmore, V Laurence, S Raouf, et al.
British Journal of Hospital Medicine (London, England : 2005)|December 8, 2010
Using bevacizumab to treat metastatic cancer: UK consensus guidelinesD Miles, J Bridgewater, P Ellis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 4, 2015
Derived neutrophil lymphocyte ratio may predict benefit from cisplatin in the advanced biliary cancer: the ABC-02 and BT-22 studiesT Grenader, S Nash, Y Plotkin, et al.
Alimentary Pharmacology & Therapeutics|September 22, 2011
Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancerJ R A Skipworth, S W M Olde Damink, C Imber, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 1, 1996
Controlled pressure reperfusion of rat pulmonary grafts yields improved function after twenty-four-hours' cold storage in University of Wisconsin solutionD N Hopkinson, M S Bhabra, N J Odom, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
ESMO Open|March 13, 2022
Plasma Tie2 trajectories identify vascular response criteria for VEGF inhibitors across advanced biliary tract, colorectal and ovarian cancersC Zhou, J O'Connor, A Backen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2014
Phase II, randomized, biomarker identification trial (MARK) for erlotinib in patients with advanced pancreatic carcinomaD Propper, I Davidenko, J Bridgewater, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 23, 2008
Primary tumour resection and survival in the palliative management of metastatic colorectal cancerA Bajwa, N Blunt, S Vyas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2013
Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trialsJ W Valle, J Furuse, M Jitlal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 29, 2011
Cancer of unknown primary: progress in the search for improved and rapid diagnosis leading toward superior patient outcomesF A Greco, K Oien, M Erlander, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 8, 2010
Chemoradiotherapy with or without induction chemotherapy for locally advanced pancreatic cancer: a UK multi-institutional experienceR Gillmore, V Laurence, S Raouf, et al.
British Journal of Hospital Medicine (London, England : 2005)|December 8, 2010
Using bevacizumab to treat metastatic cancer: UK consensus guidelinesD Miles, J Bridgewater, P Ellis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 4, 2015
Derived neutrophil lymphocyte ratio may predict benefit from cisplatin in the advanced biliary cancer: the ABC-02 and BT-22 studiesT Grenader, S Nash, Y Plotkin, et al.
Alimentary Pharmacology & Therapeutics|September 22, 2011
Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancerJ R A Skipworth, S W M Olde Damink, C Imber, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 1, 1996
Controlled pressure reperfusion of rat pulmonary grafts yields improved function after twenty-four-hours' cold storage in University of Wisconsin solutionD N Hopkinson, M S Bhabra, N J Odom, et al.
Pageof 6